在五个伤寒地方性流行的中低收入环境中伤寒结合疫苗的成本效果分析
研究评估了五种伤寒结合疫苗(TCV)接种策略在印度德里、加尔各答、肯尼亚内罗毕三个城市地区及肯尼亚卢瓦克、越南东塔两个农村地区的成本效果。采用伤寒传播动态模型模拟病例、住院、死亡、伤残调整生命年(DALY)损失及成本。与不接种相比,婴儿常规接种在德里和东塔可节省成本,在加尔各答和内罗毕具有非常高成本效果,在卢瓦克具有成本效果;但包含补种运动的策略优于常规接种。
要点
- 与不接种相比,婴儿常规接种在德里和东塔可节省成本,在加尔各答和内罗毕具有非常高成本效果,在卢瓦克具有成本效果。
- 包含补种运动的策略在德里和东塔最可能节省成本,在加尔各答、内罗毕和卢瓦克最可能超过支付意愿阈值。
- 疫苗价格影响最优策略,所需剂量数和住院率是主要不确定性来源。
核心结论
- 在大多数环境中,TCV常规接种具有成本效果,额外的一次性补种运动在经济上也是合理的。
研究设计与样本
- 研究在三个城市地区(印度德里和加尔各答、肯尼亚内罗毕)和两个农村地区(肯尼亚卢瓦克、越南东塔)评估了五种TCV接种策略的成本效果。
- 使用伤寒传播动态模型模拟病例、住院、死亡、DALY损失、治疗和干预成本。
- 从医疗付费者角度估算成本效果(以每避免一个DALY的国际美元成本表示),并评估不确定模型参数的影响。
主要发现
- 与不接种相比,婴儿常规接种(每剂1国际美元)在德里和东塔可节省成本,在加尔各答和内罗毕具有非常高成本效果,在卢瓦克具有成本效果(根据世界卫生组织阈值)。
- 包含补种运动的策略在德里和东塔最可能节省成本(概率最高)。
- 包含补种运动的策略在加尔各答最可能超过支付意愿阈值1440国际美元,在内罗毕最可能超过2300国际美元,在卢瓦克最可能超过5360国际美元。
- 疫苗价格影响最优策略,所需剂量数和住院率是主要不确定性来源。
关键数值与推荐
- 成本效果阈值:加尔各答支付意愿阈值1440国际美元,内罗毕2300国际美元,卢瓦克5360国际美元。
局限性
- 所需剂量数和住院率是主要不确定性来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Typhoid fever remains endemic in low- and middle-income countries. Programmatic use of existing vaccines is limited, but upcoming typhoid conjugate vaccines (TCVs) could warrant wider use. We evaluated the cost-effectiveness of five TCV delivery strategies in three urban areas (Delhi and Kolkata, India and Nairobi, Kenya) and two rural settings (Lwak, Kenya and Dong Thap, Vietnam) with varying incidence. METHODS AND FINDINGS: We evaluated routine infant vaccination with and without catch-up campaigns among older individuals. We used a dynamic model of typhoid transmission to simulate cases, hospitalizations, deaths, disability-adjusted life-years (DALY) lost, treatment and intervention costs. We estimated cost-effectiveness (in terms of cost in international dollars (I$) per DALY averted) from the healthcare payer perspective, and assessed how it was influenced by uncertain model parameters. Compared to no vaccination, routine infant vaccination at I$1/dose was cost-saving in Delhi and Dong Thap, "very cost-effective" in Kolkata and Nairobi, and "cost-effective" in Lwak according to World Health Organization thresholds. However, routine vaccination was not the optimal strategy compared to strategies that included a catch-up campaign, which yielded the highest probability of being cost-saving in Delhi and Dong Thap and were most likely to provide a return on investment above a willingness-to-pay threshold of I$1440 in Kolkata, I$2300 in Nairobi, and I$5360 in Lwak. Vaccine price impacted the optimal strategy, and the number of doses required and rate of hospitalization were the primary sources of uncertainty. CONCLUSION: Routine vaccination with TCV would be cost-effective in most settings, and additional one-time catch-up campaigns would also be economically justified.
引用
- Antillón M, Bilcke J, Paltiel AD, et al. Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings. Vaccine. 2017. PMID: 28527687. doi:10.1016/j.vaccine.2017.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。